You are here
Welcome to the European Journal of Cancer’s Advances in Melanoma Resource Centre.
The Resource Centre, edited by Prof. Reinhard Dummer, Dr. Paolo Ascierto and Dr. James Larkin, will provide you with the research on melanoma, including a selection of original research and review articles from some of the world’s leading journals, case studies, and other educational material. Please note that there will be no new content added to this site, current content will remain openly available to our readers.
Paper of the month – Aug / Sep 2015
Spranger S, Bao R, Gajewski TFNature. 2015 Jul 9;523(7559):231-5. doi: 10.1038/nature14404. Epub 2015 May 11
Editorial Comment by Dr. James Larkin
The systemic treatment of advanced melanoma and a number of other tumour types...
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
Stark MS, Klein K, Weide B, Haydu LE, Pflugfelder A, Tang YH, Palmer JM, Whiteman DC, Scolyer RA, Mann GJ, Thompson JF, Long GV, Barbour AP, Soyer HP, Garbe C, Herington A, Pollock PM, Hayward NK.EBioMedicine. 2015 May 12;2(7):671-680. eCollection 2015 Jul.
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With MelanomaTreated With Ipilimumab at Memorial Sloan Kettering Cancer Center
Horvat TZ, Adel NG, Dang TO, Momtaz P, Postow MA, Callahan MK, Carvajal RD, Dickson MA, D'Angelo SP, Woo KM, Panageas KS, Wolchok JD, Chapman PB.J Clin Oncol. 2015 Aug 17.
Buchbinder EI, Sosman JA, Lawrence DP, McDermott DF, Ramaiya NH, Van den Abbeele AD, Linette GP, Giobbie-Hurder A, Hodi FS.Cancer. 2015 Aug 11. doi: 10.1002/cncr.29622
About the editors
- Professor Dummer is Vice-Chairman of the Department of Dermatology and Head of the Skin Cancer Unit at the University Hospital...
- Dr James Larkin, FRCP PhD is a Medical Oncologist specialising in the treatment of patients with cancer of the kidney...
- Dr. Paolo A. Ascierto is Director at the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute ‘Fondazione...